GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Contineum Therapeutics Inc (NAS:CTNM) » Definitions » Beneish M-Score

Contineum Therapeutics (Contineum Therapeutics) Beneish M-Score


View and export this data going back to 2024. Start your Free Trial

What is Contineum Therapeutics Beneish M-Score?

Contineum Therapeutics does not have enough data to calculate Beneish M-Score.


Contineum Therapeutics Beneish M-Score Historical Data

The historical data trend for Contineum Therapeutics's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Contineum Therapeutics Beneish M-Score Chart

Contineum Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Beneish M-Score
- - -

Contineum Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial - - - - -

Competitive Comparison of Contineum Therapeutics's Beneish M-Score

For the Biotechnology subindustry, Contineum Therapeutics's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Contineum Therapeutics's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Contineum Therapeutics's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Contineum Therapeutics's Beneish M-Score falls into.



Contineum Therapeutics Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Contineum Therapeutics's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Contineum Therapeutics (Contineum Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
10578 Science Center Drive, Suite 200, San Diego, CA, USA, 92121
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Contineum Therapeutics (Contineum Therapeutics) Headlines

From GuruFocus